5 Mar 2018 07:00
5 March 2018
Â
Venture Life Group plc
("Venture Life" or the "Group")
Â
Notice of Results
Analyst & investor briefings
Â
Venture Life Group plc (AIM: VLG), the international consumer healthcare group focused on developing, manufacturing and commercialising products for the self-care market, announces that it will release its final results for the year ended 31 December 2017 on 22 March 2018.
Â
Analyst briefing
A briefing for analysts will take place at the offices of Walbrook PR, 4 Lombard St., London EC3V 9HD at 9.30am on Thursday, 22 March 2018.
Â
Investor briefing
A presentation to private investors will take place at Copper Bar, Balls Brothers, 6 Adams Court, Old Broad Street, London EC2N 1DX on Monday, 26 March 2018 from 4.30pm for a 4.45pm start and will be followed by drinks.
Â
If you would like to register to attend either briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email venturelife@walbrookpr.com.
Â
For further information, please contact:
Â
Venture Life Group PLC | +44 (0) 1344 742870 | |
Jerry Randall, Chief Executive Officer | ||
Adrian Crockett, Chief Financial Officer | ||
Walbrook PR | venturelife@walbrookpr.com or +44 (0) 20 7933 8780 | |
Paul McManus | +44 (0) 7980 541 893 | |
Anna Dunphy | +44 (0) 7876 741 001 | |
Â
Â
About Venture Life (www.venture-life.com)
Â
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising self-care products globally. The Group's product range and pipeline currently includes the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.
Â
The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.
Â
Through its Development & Manufacturing business, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
Â
Â